Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 162

1.

How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice.

Johansson PA, Farup PG, Bracco A, Vandvik PO.

BMC Gastroenterol. 2010 Mar 17;10:31. doi: 10.1186/1471-230X-10-31.

PMID:
20233451
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Prevalence, comorbidity and impact of irritable bowel syndrome in Norway.

Vandvik PO, Lydersen S, Farup PG.

Scand J Gastroenterol. 2006 Jun;41(6):650-6.

PMID:
16716962
[PubMed - indexed for MEDLINE]
3.

Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications.

Vandvik PO, Wilhelmsen I, Ihlebaek C, Farup PG.

Aliment Pharmacol Ther. 2004 Nov 15;20(10):1195-203.

PMID:
15569123
[PubMed - indexed for MEDLINE]
Free Article
4.

Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study.

Brun-Strang C, Dapoigny M, Lafuma A, Wainsten JP, Fagnani F.

Eur J Gastroenterol Hepatol. 2007 Dec;19(12):1097-103. Review.

PMID:
17998835
[PubMed - indexed for MEDLINE]
5.

Comorbidity and use of health-care services among irritable bowel syndrome sufferers.

Hillilä MT, Siivola MT, Färkkilä MA.

Scand J Gastroenterol. 2007 Jul;42(7):799-806.

PMID:
17558902
[PubMed - indexed for MEDLINE]
6.

The impact of somatization on the use of gastrointestinal health-care resources in patients with irritable bowel syndrome.

Spiegel BM, Kanwal F, Naliboff B, Mayer E.

Am J Gastroenterol. 2005 Oct;100(10):2262-73.

PMID:
16181379
[PubMed - indexed for MEDLINE]
7.

Societal costs for irritable bowel syndrome--a population based study.

Hillilä MT, Färkkilä NJ, Färkkilä MA.

Scand J Gastroenterol. 2010 May;45(5):582-91. doi: 10.3109/00365521003637211.

PMID:
20166844
[PubMed - indexed for MEDLINE]
8.

Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior.

Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P.

Am J Gastroenterol. 2008 May;103(5):1229-39; quiz 1240. doi: 10.1111/j.1572-0241.2007.01740.x. Epub 2008 Mar 26.

PMID:
18371141
[PubMed - indexed for MEDLINE]
9.

Costs of irritable bowel syndrome in the UK and US.

Maxion-Bergemann S, Thielecke F, Abel F, Bergemann R.

Pharmacoeconomics. 2006;24(1):21-37. Review.

PMID:
16445300
[PubMed - indexed for MEDLINE]
10.

Dyspepsia in general practice: incidence, risk factors, comorbidity and mortality.

Wallander MA, Johansson S, Ruigómez A, García Rodríguez LA, Jones R.

Fam Pract. 2007 Oct;24(5):403-11. Epub 2007 Aug 28.

PMID:
17728288
[PubMed - indexed for MEDLINE]
Free Article
11.

The burden cost of French patients suffering from irritable bowel syndrome.

Le Pen C, Ruszniewski P, Gaudin AF, Amouretti M, Bommelaer G, Frexinos J, Poynard T, Maurel F, Priol G, Bertin C.

Scand J Gastroenterol. 2004 Apr;39(4):336-43.

PMID:
15125465
[PubMed - indexed for MEDLINE]
12.

Comorbidity in irritable bowel syndrome.

Whitehead WE, Palsson OS, Levy RR, Feld AD, Turner M, Von Korff M.

Am J Gastroenterol. 2007 Dec;102(12):2767-76. Epub 2007 Sep 26.

PMID:
17900326
[PubMed - indexed for MEDLINE]
13.

Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.

Paré P, Gray J, Lam S, Balshaw R, Khorasheh S, Barbeau M, Kelly S, McBurney CR.

Clin Ther. 2006 Oct;28(10):1726-35; discussion 1710-1.

PMID:
17157129
[PubMed - indexed for MEDLINE]
14.

Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial.

Kennedy TM, Chalder T, McCrone P, Darnley S, Knapp M, Jones RH, Wessely S.

Health Technol Assess. 2006 Jun;10(19):iii-iv, ix-x, 1-67.

PMID:
16729918
[PubMed - indexed for MEDLINE]
Free Article
15.

Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease.

De Vries DR, Van Herwaarden MA, Baron A, Smout AJ, Samsom M.

Scand J Gastroenterol. 2007 Aug;42(8):951-6.

PMID:
17613924
[PubMed - indexed for MEDLINE]
16.

Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia.

Corsetti M, Caenepeel P, Fischler B, Janssens J, Tack J.

Am J Gastroenterol. 2004 Jun;99(6):1152-9.

PMID:
15180740
[PubMed - indexed for MEDLINE]
17.

Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective.

Longstreth GF, Wilson A, Knight K, Wong J, Chiou CF, Barghout V, Frech F, Ofman JJ.

Am J Gastroenterol. 2003 Mar;98(3):600-7.

PMID:
12650794
[PubMed - indexed for MEDLINE]
18.

Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.

Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD.

Am J Gastroenterol. 2003 Nov;98(11):2454-9.

PMID:
14638348
[PubMed - indexed for MEDLINE]
19.

Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett's esophagus.

Neumann H, Monkemuller K, Kandulski A, Malfertheiner P.

Dig Dis. 2008;26(3):243-7. doi: 10.1159/000121354. Epub 2008 May 7.

PMID:
18463443
[PubMed - indexed for MEDLINE]
20.

Irritable bowel syndrome and gastroesophageal reflux disease in primary care: is there a link?

Ruigómez A, Wallander MA, Johansson S, Rodríguez LA.

Dig Dis Sci. 2009 May;54(5):1079-86. doi: 10.1007/s10620-008-0462-0. Epub 2008 Aug 22.

PMID:
18720002
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk